Elon Musk and Mark Zuckerberg reportedly sleep on it. But Eight Sleep, the startup behind the $2,999 Pod mattress cover, no longer wants to be known just for its billionaire fan club. The company is now chasing something far bigger than celebrity endorsements: FDA clearance to detect and treat sleep apnea — a move that could turn a luxury sleep gadget into a medical device that health insurers actually pay for.
A Luxury Sleep Brand's Medical Ambition
Eight Sleep's cofounder and CEO, Matteo Franceschetti, told Fortune that the company's filing with the U.S. Food and Drug Administration is progressing "fairly smoothly." The company began pursuing clearance for its sleep apnea detection and mitigation technologies in 2025 and is now conducting clinical studies to back its submissions.
The shift is strategic. Sleep apnea is a serious condition affecting an estimated 30 million Americans, most of whom remain undiagnosed. If Eight Sleep can prove its Pod can reliably detect and help manage the condition, it moves from being a discretionary luxury purchase to a medically necessary one.
Why This Pivot Matters for Everyday Sleepers
For most people, a $3,000 mattress cover is out of reach. But if Eight Sleep secures FDA clearance, the economics change. Insurance reimbursement could make the technology accessible to a far wider population than the tech elite who currently buy the Pod.
Sleep apnea is linked to heart disease, stroke, high blood pressure, and daytime fatigue. Current treatments like CPAP machines are effective but notoriously uncomfortable — many patients abandon them within months. A mattress cover that could detect breathing disruptions and respond with temperature or positional adjustments would offer an alternative that fits naturally into a person's existing sleep setup.
From Celebrity Endorsements to Clinical Evidence
Eight Sleep's journey has been defined by its high-profile users. Musk and Zuckerberg have both publicly praised the product, giving the brand a cultural cachet that most hardware startups can only dream of. But celebrity buzz doesn't impress regulators.
The company has published only one independent study on the Pod so far, according to the original report. That's a thin evidence base for a company seeking to make medical claims. The clinical studies now underway will be critical — not just for FDA approval, but for convincing the medical community that a consumer sleep gadget can hold its own against established medical devices.
Who Stands to Benefit Most
The people most likely to benefit from this pivot are the millions of undiagnosed sleep apnea sufferers. Many don't realize their fatigue, morning headaches, or mood swings stem from breathing interruptions during sleep. A device that monitors sleep continuously — without the discomfort of a mask or sensors strapped to the body — could encourage more people to seek diagnosis and treatment.
For existing Eight Sleep customers, the upgrade path is clear: their $3,000 purchase could become more valuable if it gains medical credibility. For new customers, insurance coverage could dramatically lower the effective cost.
What Eight Sleep's CEO Is Saying
Franceschetti's comments to Fortune suggest confidence in the regulatory timeline, though he stopped short of predicting a specific approval date. The company's framing is deliberate: it wants to be seen as a healthcare company that happens to make a premium sleep product, not a luxury brand dabbling in health features.
This positioning matters for valuation and investor sentiment. Healthcare companies command different multiples than consumer hardware startups. If Eight Sleep can credibly claim the medical mantle, it opens doors to partnerships with sleep clinics, health systems, and insurers.
The Science Behind the Pod's Sleep Apnea Potential
The Pod works by actively regulating bed temperature and collecting biometric data through sensors embedded in the cover. For sleep apnea detection, the company would need to demonstrate that these sensors can reliably identify breathing patterns associated with apnea events — pauses in breathing that can last 10 seconds or longer.
Mitigation is a harder challenge. CPAP machines work by keeping airways open with pressurized air. A mattress cover cannot do that. Eight Sleep's approach likely involves temperature and positional adjustments — for example, cooling the bed to encourage movement or using data to alert users to seek medical evaluation. The company has not disclosed the full mechanism of its mitigation technology.
What's Confirmed vs. What Remains Unclear
Confirmed: Eight Sleep has filed with the FDA for sleep apnea detection and mitigation technologies. The company began this process in 2025. Clinical studies are underway. CEO Matteo Franceschetti described the process as progressing "fairly smoothly."
Unclear: The specific timeline for FDA approval, the full clinical evidence being gathered, how the mitigation technology works in practice, and whether insurers will actually reimburse the device. Only one independent study has been published, and its findings have not been detailed in the original report.
Why Eight Sleep's Technology Advantage Matters
Eight Sleep's core differentiator is its sensor-rich, actively cooled and heated mattress cover — a product category it essentially created. The company has spent years refining its biometric tracking, temperature control algorithms, and user experience. This gives it a head start over traditional medical device makers, which excel at clinical rigor but often lag in consumer design.
The network effect is also relevant: as more users sleep on the Pod, the company accumulates more sleep data, which can improve its detection algorithms. This data moat is difficult for competitors to replicate quickly.
Risks and the Skeptics' View
The path to FDA clearance is demanding, and consumer sleep trackers have a mixed record when it comes to medical claims. The FDA requires substantial evidence that a device is safe and effective for its intended use. One published independent study is unlikely to be sufficient.
There's also the question of whether temperature-based mitigation can meaningfully improve sleep apnea outcomes. Some sleep specialists are skeptical that a mattress cover can deliver the therapeutic benefit of CPAP or oral appliances. And even with FDA clearance, insurance coverage is not guaranteed — it depends on coding, pricing, and clinical guidelines that can take years to develop.
The Broader Sleep Tech Wave
Eight Sleep's pivot reflects a wider trend: consumer sleep technology is moving toward medical legitimacy. Companies like Apple and Samsung have added sleep apnea detection to smartwatches, and the FDA has shown willingness to clear consumer devices for health monitoring. The line between wellness gadget and medical device is blurring.
If Eight Sleep succeeds, it could pave the way for other premium sleep products to pursue regulatory approval, expanding the market for at-home sleep care.
What Should You Do Now
If you suspect you have sleep apnea, don't wait for a mattress cover to diagnose you. Consult a physician or a sleep specialist. A proper diagnosis typically involves a sleep study, either in a clinic or at home with a validated device.
For current Eight Sleep owners, keep an eye on software updates and company announcements — the Pod's capabilities may expand as clinical data rolls in. For prospective buyers, consider whether you're paying for a luxury comfort product today or investing in a device that may gain medical utility later. The $2,999 price tag is a significant commitment either way.
What Happens Next
The coming months will reveal whether Eight Sleep's FDA filing translates into clearance. The company's clinical studies will need to produce compelling data, and regulators will scrutinize both detection accuracy and the safety of any mitigation features.
If approved, the bigger test will be market adoption: will insurers cover it, will doctors recommend it, and will patients prefer it over CPAP? Eight Sleep's ambition is clear — but the healthcare industry moves slowly, and regulatory approval is only the first step.
Our Take
Eight Sleep's pivot from luxury gadget to medical device is a smart business move, but it's also a genuine test of whether consumer sleep tech can deliver real clinical value. The company has the brand recognition, the data infrastructure, and the product design to make a compelling case. What it lacks is the clinical evidence — and that can't be bought or marketed into existence.
For the millions of people struggling with undiagnosed sleep apnea, the promise of a comfortable, unobtrusive monitoring and treatment option is genuinely exciting. But the gap between a promising concept and a proven medical device is wide. Eight Sleep's next few years will determine whether it becomes a healthcare company in name only — or one that actually changes how sleep apnea is managed.
Frequently Asked Questions
What is Eight Sleep's Pod mattress cover?
The Pod is a $2,999 mattress cover that actively regulates bed temperature and tracks sleep biometrics. It's known for its high-profile users, including Elon Musk and Mark Zuckerberg, and is now being positioned for FDA clearance as a sleep apnea detection and mitigation device.
Is Eight Sleep FDA approved for sleep apnea?
Not yet. Eight Sleep began pursuing FDA clearance in 2025 and is currently conducting clinical studies. CEO Matteo Franceschetti said the filing is progressing "fairly smoothly," but no approval has been announced.
How does the Pod detect sleep apnea?
The Pod uses sensors embedded in the mattress cover to collect biometric data during sleep. The company is working to demonstrate that this data can reliably identify breathing patterns associated with apnea events, though the full mechanism has not been publicly detailed.
Will insurance cover the Eight Sleep Pod if it gets FDA clearance?
Not automatically. FDA clearance is a prerequisite, but insurance coverage depends on coding, pricing decisions, and clinical guidelines. It could take years before insurers decide whether to reimburse the device, even if the FDA approves it.
